Inventor
DESJARDINS CODY A
US33 patents
Patents
33 patentsUS11771776B2Oct 3, 2023
Muscle targeting complexes and uses thereof for treating dystrophinopathies
DYNE THERAPEUTICS INC32 citations98
US11759525B1Sep 19, 2023
Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy
DYNE THERAPEUTICS INC32 citations98
US11679161B2Jun 20, 2023
Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy
DYNE THERAPEUTICS INC38 citations98
US11672872B2Jun 13, 2023
Anti-transferrin receptor antibody and uses thereof
DYNE THERAPEUTICS INC37 citations98
US11648318B2May 16, 2023
Anti-transferrin receptor (TFR) antibody and uses thereof
DYNE THERAPEUTICS INC37 citations98
US11638761B2May 2, 2023
Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular dystrophy
DYNE THERAPEUTICS INC47 citations98
US12173078B2Dec 24, 2024
Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide
DYNE THERAPEUTICS INC14 citations95
US12097263B2Sep 24, 2024
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
DYNE THERAPEUTICS INC18 citations95
US12018087B2Jun 25, 2024
Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and methods of delivering oligonucleotide to a subject
DYNE THERAPEUTICS INC23 citations95
US11911484B2Feb 27, 2024
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
DYNE THERAPEUTICS INC28 citations95
US12239717B2Mar 4, 2025
Muscle targeting complexes and uses thereof for treating dystrophinopathies
DYNE THERAPEUTICS INC13 citations94
US12239716B2Mar 4, 2025
Muscle targeting complexes and uses thereof for treating dystrophinopathies
DYNE THERAPEUTICS INC13 citations94
US12144868B2Nov 19, 2024
Muscle targeting complexes and uses thereof for treating dystrophinopathies
DYNE THERAPEUTICS INC14 citations94
US12144867B2Nov 19, 2024
Muscle targeting complexes and uses thereof for treating dystrophinopathies
DYNE THERAPEUTICS INC14 citations94
US12102687B2Oct 1, 2024
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
DYNE THERAPEUTICS INC17 citations94
US11986537B2May 21, 2024
Muscle targeting complexes and uses thereof for treating dystrophinopathies
DYNE THERAPEUTICS INC24 citations94
US11969475B2Apr 30, 2024
Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy
DYNE THERAPEUTICS INC25 citations94
US11844843B2Dec 19, 2023
Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy
DYNE THERAPEUTICS INC30 citations94
US11839660B2Dec 12, 2023
Anti-transferrin receptor antibody and uses thereof
DYNE THERAPEUTICS INC30 citations94
US11633498B2Apr 25, 2023
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
DYNE THERAPEUTICS INC37 citations94
US11931421B2Mar 19, 2024
Muscle targeting complexes and formulations for treating myotonic dystrophy
DYNE THERAPEUTICS INC26 citations92
US12329824B1Jun 17, 2025
Muscle targeting complexes and uses thereof for treating dystrophinopathies
DYNE THERAPEUTICS INC4 citations86
US12319743B2Jun 3, 2025
Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject
DYNE THERAPEUTICS INC5 citations86
US12280122B2Apr 22, 2025
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
DYNE THERAPEUTICS INC5 citations86
US12128109B2Oct 29, 2024
Muscle targeting complexes and formulations for treating dystrophinopathies
DYNE THERAPEUTICS INC17 citations82
US12370264B1Jul 29, 2025
Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject
DYNE THERAPEUTICS INC2 citations75
US12496352B2Dec 16, 2025
Muscle targeting complexes and uses thereof for treating myotonic dystrophy
DYNE THERAPEUTICS INC0 citations63
US12460011B2Nov 4, 2025
Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering an oligonucleotide to a subject
DYNE THERAPEUTICS INC0 citations63
US12428487B2Sep 30, 2025
Complexes comprising an anti-transferrin receptor antibody linked to an oligonicleotide and method of delivering oligonucleotide to a subject
DYNE THERAPEUTICS INC0 citations63
US12440575B2Oct 14, 2025
Muscle targeting complexes and uses thereof for treating dystrophinopathies
DYNE THERAPEUTICS INC0 citations62
US12403203B2Sep 2, 2025
Muscle targeting complexes and uses thereof for treating dystrophinopathies
DYNE THERAPEUTICS INC0 citations62
US12397062B2Aug 26, 2025
Muscle targeting complexes and uses thereof for treating dystrophinopathies
DYNE THERAPEUTICS INC0 citations62
US12440574B2Oct 14, 2025
Muscle targeting complexes and formulations for treating myotonic dystrophy
DYNE THERAPEUTICS INC0 citations61